Boston Scientific Settles Guidant Heart Devices Allegations for $30 Million

Boston Scientific Inc., already embroiled in transvaginal mesh litigation, agreed to pay $30 million stemming from claims that they knowingly sold defective heart devices that were implanted in Medicare patients.  Boston Scientific acquired Guidant in 2006 and bought the company for $27 billion. From 2002 to 2005, Guidant knowingly sold the defibrillator devices even though [...]